These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital. Park SD, Uh Y, Lee G, Lim K, Kim JB, Jeong SH. APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475 [Abstract] [Full Text] [Related]
5. [Plasmid-mediated cephalosporinase among extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae]. Wang QT, Liu YM, Wang H, Sun HL, Chen MJ, Du XL. Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):487-90. PubMed ID: 15312399 [Abstract] [Full Text] [Related]
6. [Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures]. Sarı AN, Biçmen M, Gülay Z. Mikrobiyol Bul; 2013 Oct; 47(4):582-91. PubMed ID: 24237427 [Abstract] [Full Text] [Related]
9. Characterization of plasmid mediated AmpC producing Escherichia coli clinical isolates from a tertiary care hospital in South India. Chakraborty A, Adhikari P, Shenoy S, Saralaya V. Indian J Pathol Microbiol; 2014 Oct; 57(2):255-8. PubMed ID: 24943759 [Abstract] [Full Text] [Related]
12. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae]. Wang Y, Li ZH. Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953 [Abstract] [Full Text] [Related]
13. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia. Palasubramaniam S, Muniandy S, Navaratnam P. J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644 [Abstract] [Full Text] [Related]
16. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis. Tan TY, Ng SY, Teo L, Koh Y, Teok CH. J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079 [Abstract] [Full Text] [Related]
17. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases. Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH. J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086 [Abstract] [Full Text] [Related]
18. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. Denisuik AJ, Lagacé-Wiens PR, Pitout JD, Mulvey MR, Simner PJ, Tailor F, Karlowsky JA, Hoban DJ, Adam HJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance. J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779 [Abstract] [Full Text] [Related]
19. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings. Ibrahimagić A, Bedenić B, Kamberović F, Uzunović S. J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292 [Abstract] [Full Text] [Related]
20. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype. Jørgensen RL, Nielsen JB, Friis-Møller A, Fjeldsøe-Nielsen H, Schønning K. J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787 [Abstract] [Full Text] [Related] Page: [Next] [New Search]